A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design
Magnetic resonance imaging (MRI) is a sensitive imaging modality for identifying inflammatory and/or demyelinating lesions, which is critical for a clinical diagnosis of MS and evaluating drug responses. There are many unique means of probing brain tissue status, including conventional T1 and T2 wei...
Main Authors: | Ewart Mark Haacke, Evanthia Bernitsas, Karthik Subramanian, David Utriainen, Vinay Kumar Palutla, Kiran Yerramsetty, Prashanth Kumar, Sean K. Sethi, Yongsheng Chen, Zahid Latif, Pavan Jella, Sara Gharabaghi, Ying Wang, Xiaomeng Zhang, Robert A. Comley, John Beaver, Yanping Luo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/1/77 |
Similar Items
-
Fulminant inflammatory demyelination presenting as stroke‐in‐evolution in an elderly subject
by: Simone Sacco, et al.
Published: (2021-08-01) -
Phenotyping variants of tumefactive demyelinating lesions according to clinical and radiological features—A case series
by: Thérèse Boyle, et al.
Published: (2023-02-01) -
Neuroimaging and clinicopathological differences between tumefactive demyelinating lesions and sentinel lesions of primary central nervous system lymphoma
by: Chenjing Sun, et al.
Published: (2022-08-01) -
Demyelinating Disease? Central Nervous System Lymphoma?
by: Ufuk Ergün, et al.
Published: (2008-06-01) -
Focal Hand Dystonia as a Sign of Demyelinating Attack in Multipl Sclerosis: 'Report of Three Cases’
by: Özge Öcek, et al.
Published: (2014-12-01)